BioGaia Interim report January - June 2021
Second quarter 2021 · Net sales amounted to SEK 203.1 million (244.7), a decrease of 17% (excluding foreign exchange effects, -8%). The change in sales was affected by higher comparative figures since the corresponding period last year was positively affected by Covid-19 related inventory build-up at many of our customers. · Net sales in the Paediatrics segment reached SEK 161.1 million (199.2), a decrease of 19%. · Net sales in the Adult Health segment amounted to SEK 40.9 million (44.4), a decrease of 8%. · Operating expenses amounted to SEK 81.6 million (84.2), a decrease